Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 4

Results: 38

Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al.

Published in:

2008

By:

Westerman, D.;
Juneja, S.

Publication type:

Letter

A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.

Published in:

2008

By:

Schnittger, S.;
Bacher, U.;
Kern, W.;
Haferlach, T.;
Hertenstein, B.;
Haferlach, C.

Publication type:

Letter

Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study.

Published in:

2008

By:

Zangrando, A.;
Intini, F.;
te Kronnie, G.;
Basso, G.

Publication type:

Letter

Clonal expansion of non-leukemic cells expressing two novel MLL–ELL variants differing in transforming activity.

Published in:

2008

By:

Takeuchi, M.;
Nakaseko, C.;
Miyagi, S.;
Takeda, Y.;
Ozawa, S.;
Ohwada, C.;
Cho, R.;
Nishimura, M.;
Saito, Y.;
Iwama, A.

Publication type:

Letter

Reply to ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al.’ by Westerman et al.

Published in:

2008

By:

Alvarez-Larrán, A.;
Cervantes, F.;
Besses, C.

Publication type:

Letter

Erythroid variant of chronic myelogenous leukemia.

Published in:

2008

By:

Talreja, N.;
Abdulhaq, H.;
Shadduck, R. K.;
Rossetti, J.;
Jalil, A.;
Makary, A.;
Lister, J.

Publication type:

Letter

Reply to ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán et al. Leukemia 2007; 21: 1218–1223’.

Published in:

2008

By:

Westerman, D.;
Juneja, S.

Publication type:

Letter

Reply to Westerman et al.: ‘Re: Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients. Alvarez-Larrán A et al. Leukemia 2007; 21: 1218–1223’

Published in:

2008

By:

Alvarez-Larrán, A.;
Cervantes, F.;
Besses, C.

Publication type:

Letter

Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients.

Published in:

2008

By:

Butcher, C. M.;
Hahn, U.;
To, L. B.;
Gecz, J.;
Wilkins, E. J.;
Scott, H. S.;
Bardy, P. G.;
D'Andrea, R. J.

Publication type:

Letter

Contribution of GM-CSF and IL-8 to the CD44-induced differentiation of acute monoblastic leukemia.

Published in:

2008

By:

Delaunay, J.;
Lecomte, N.;
Bourcier, S.;
Qi, J.;
Gadhoum, Z.;
Durand, L.;
Chomienne, C.;
Robert-Lézénès, J.;
Smadja-Joffe, F.

Publication type:

Letter

Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia.

Published in:

2008

By:

Quintás-Cardama, A.;
Gibbons, D. L.;
Cortes, J.;
Bobadilla, D.;
Slovak, M. L.;
Kantarjian, H.;
Abruzzo, L. V.

Publication type:

Letter

Effect of parental history of cancer on the development of second neoplasms after lymphoma at the same site than the parents.

Published in:

2008

By:

Lorenzo Bermejo, J.;
Sundquist, J.;
Hemminki, K.

Publication type:

Letter

The genetic characterization of acute promyelocytic leukemia with cryptic t(15;17) including a new recurrent additional cytogenetic abnormality i(17)(q10).

Published in:

2008

By:

Kim, M.;
Lim, J.;
Kim, Y.;
Han, K.;
Lee, D. H.;
Chung, N. G.;
Cho, B.;
Kim, H. K.;
Eom, K. S.;
Min, C.-K.;
Min, W.-S.

Publication type:

Letter

Proteasome inhibition therapies in childhood cancer.

Published in:

2008

By:

Zaman, F.;
Fadeel, B.;
Sävendahl, L.

Publication type:

Letter

Reply to ‘Proteasome inhibition therapies in childhood cancer’ by Zaman et al.

Published in:

2008

By:

Terpos, E.;
Sezer, O.

Publication type:

Letter

The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2<sup>V617F</sup>.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 740, doi. 10.1038/sj.leu.2405049

By:

Guerini, V.;
Barbui, V.;
Spinelli, O.;
Salvi, A.;
Dellacasa, C.;
Carobbio, A.;
Introna, M.;
Barbui, T.;
Golay, J.;
Rambaldi, A.

Publication type:

Article

The role of CALM-AF10 gene fusion in acute leukemia.

Published in:

2008

By:

Caudell, D.;
Aplan, P. D.

Publication type:

journal article

KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 826, doi. 10.1038/sj.leu.2405081

By:

Haddad, L.;
El Hajj, H.;
Abou-Merhi, R.;
Kfoury, Y.;
Mahieux, R.;
El-Sabban, M.;
Bazarbachi, A.

Publication type:

Article

Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.

Published in:

2008

By:

Van Vlierberghe, P.;
Homminga, I.;
Zuurbier, L.;
Gladdines-Buijs, J.;
van Wering, E. R.;
Horstmann, M.;
Beverloo, H. B.;
Pieters, R.;
Meijerink, J. P. P.

Publication type:

journal article

E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 723, doi. 10.1038/sj.leu.2405084

By:

Zhong, C.-h.;
Prima, V.;
Liang, X.;
Frye, C.;
McGavran, L.;
Meltesen, L.;
Wei, Q.;
Boomer, T.;
Varella-Garcia, M.;
Gump, J.;
Hunger, S. P.

Publication type:

Article

Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.

Published in:

2008

By:

Konig, H.;
Holtz, M.;
Modi, H.;
Manley, P.;
Holyoake, T. L.;
Forman, S. J.;
Bhatia, R.

Publication type:

journal article

Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 842, doi. 10.1038/sj.leu.2405087

By:

San-Miguel, J. F.;
Richardson, P. G.;
Sonneveld, P.;
Schuster, M. W.;
Irwin, D.;
Stadtmauer, E. A.;
Facon, T.;
Harousseau, J.-L.;
Ben-Yehuda, D.;
Lonial, S.;
Goldschmidt, H.;
Reece, D.;
Bladé, J.;
Boccadoro, M.;
Cavenagh, J. D.;
Neuwirth, R.;
Boral, A. L.;
Esseltine, D.-L.;
Anderson, K. C.

Publication type:

Article

Suppression of abnormal karyotype predicts superior survival in multiple myeloma.

Published in:

2008

By:

Arzoumanian, V.;
Hoering, A.;
Sawyer, J.;
van Rhee, F.;
Bailey, C.;
Gurley, J.;
Shaughnessy, J. D.;
Anaissie, E.;
Crowley, J.;
Barlogie, B.;
Shaughnessy, J D Jr

Publication type:

journal article

Expression and mutation status of candidate kinases in multiple myeloma.

Published in:

2008

By:

Claudio, J. O.;
Zhan, F.;
Zhuang, L.;
Khaja, R.;
Zhu, Y. X.;
Sivananthan, K.;
Trudel, S.;
Masih-Khan, E.;
Fonseca, R.;
Bergsagel, P. L.;
Scherer, S. W.;
Shaughnessy, J.;
Stewart, A. K.

Publication type:

Correction Notice

Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 756, doi. 10.1038/sj.leu.2405097

By:

Tefferi, A.;
Lasho, T. L.;
Huang, J.;
Finke, C.;
Mesa, R. A.;
Li, C. Y.;
Wu, W.;
Hanson, C. A.;
Pardanani, A.

Publication type:

Article

Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.

Published in:

2008

By:

Zhang, W.;
Konopleva, M.;
Ruvolo, V. R.;
McQueen, T.;
Evans, R. L.;
Bornmann, W. G.;
McCubrey, J.;
Cortes, J.;
Andreeff, M.

Publication type:

journal article

Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha.

Published in:

2008

By:

Bararia, D.;
Trivedi, A. K.;
Zada, A. A. Peer;
Greif, P. A.;
Mulaw, M. A.;
Christopeit, M.;
Hiddemann, W.;
Bohlander, S. K.;
Behre, G.

Publication type:

journal article

High titer autoantibodies to GM-CSF in patients with AML, CML and MDS are associated with active disease.

Published in:

2008

By:

Sergeeva, A.;
Ono, Y.;
Rios, R.;
Molldrem, J. J.

Publication type:

journal article

MDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2.

Published in:

2008

By:

Gu, L.;
Zhu, N.;
Findley, H. W.;
Zhou, M.

Publication type:

journal article

Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 835, doi. 10.1038/leu.2008.12

By:

Ehlers, A.;
Oker, E.;
Bentink, S.;
Lenze, D.;
Stein, H.;
Hummel, M.

Publication type:

Article

C/EBPalpha, do not forget your TIP60.

Published in:

2008

By:

C. W. E. So;
van der Reijden, B. A.;
So, C W E

Publication type:

Editorial

Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells.

Published in:

2008

By:

Inoue, S.;
Walewska, R.;
Dyer, M. J. S.;
Cohen, G. M.

Publication type:

journal article

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

Published in:

2008

By:

Steelman, L. S.;
Abrams, S. L.;
Whelan, J.;
Bertrand, F. E.;
Ludwig, D. E.;
Bäsecke, J.;
Libra, M.;
Stivala, F.;
Milella, M.;
Tafuri, A.;
Lunghi, P.;
Bonati, A.;
Martelli, A. M.;
McCubrey, J. A.;
Bäsecke, J

Publication type:

journal article

Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 708, doi. 10.1038/leu.2008.27

By:

McCubrey, J. A.;
Steelman, L. S.;
Abrams, S. L.;
Bertrand, F. E.;
Ludwig, D. E.;
Bäsecke, J.;
Libra, M.;
Stivala, F.;
Milella, M.;
Tafuri, A.;
Lunghi, P.;
Bonati, A.;
Martelli, A. M.

Publication type:

Article

A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy.

Published in:

2008

By:

Bergsagel, P. L.

Publication type:

Editorial

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 791, doi. 10.1038/leu.2008.3

By:

Liu, J.;
Joha, S.;
Idziorek, T.;
Corm, S.;
Hetuin, D.;
Philippe, N.;
Preudhomme, C.;
Quesnel, B.

Publication type:

Article

Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1<sup>T315I</sup> and other mutants compared to direct sequencing of the ABL1 kinase domain.

Published in:

2008

By:

Quintás-Cardama, A.;
Gibbons, D. L.;
Kantarjian, H.;
Talpaz, M.;
Donato, N.;
Cortes, J.

Publication type:

Letter

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2008, v. 22, n. 4, p. 771, doi. 10.1038/leu.2008.5

By:

Flohr, T.;
Schrauder, A.;
Cazzaniga, G.;
Panzer-Grümayer, R.;
van der Velden, V.;
Fischer, S.;
Stanulla, M.;
Basso, G.;
Niggli, F. K.;
Schäfer, B. W.;
Sutton, R.;
Koehler, R.;
Zimmermann, M.;
Valsecchi, M. G.;
Gadner, H.;
Masera, G.;
Schrappe, M.;
van Dongen, J. J. M.;
Biondi, A.;
Bartram, C. R.

Publication type:

Article